NDC 10019-937

CYCLOPHOSPHAMIDE

Cyclophosphamide

CYCLOPHOSPHAMIDE is a Intravenous; Oral Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Cyclophosphamide.

Product ID10019-937_0b5bf0e3-7aff-42fb-a426-88ea701a6c08
NDC10019-937
Product TypeHuman Prescription Drug
Proprietary NameCYCLOPHOSPHAMIDE
Generic NameCyclophosphamide
Dosage FormInjection, Powder, For Solution
Route of AdministrationINTRAVENOUS; ORAL
Marketing Start Date2008-05-21
Marketing CategoryANDA / ANDA
Application NumberANDA040745
Labeler NameBaxter Healthcare Corporation
Substance NameCYCLOPHOSPHAMIDE
Active Ingredient Strength2 g/100mL
Pharm ClassesAlkylating Activity [MoA], Alkylating Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 10019-937-01

1 VIAL, SINGLE-DOSE in 1 CARTON (10019-937-01) > 100 mL in 1 VIAL, SINGLE-DOSE (10019-937-10)
Marketing Start Date2008-05-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10019-937-10 [10019093710]

CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA040745
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2008-05-21

NDC 10019-937-01 [10019093701]

CYCLOPHOSPHAMIDE INJECTION, POWDER, FOR SOLUTION
Marketing CategoryANDA
Application NumberANDA040745
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2008-05-21

Drug Details

Active Ingredients

IngredientStrength
CYCLOPHOSPHAMIDE2 g/100mL

OpenFDA Data

SPL SET ID:6bae5c14-9e87-4fb6-ae9c-4d875c1ecffe
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1734921
  • 1734919
  • 1734917

    • Pharmacological Class

    • Alkylating Activity [MoA]
    • Alkylating Drug [EPC]

    NDC Crossover Matching brand name "CYCLOPHOSPHAMIDE" or generic name "Cyclophosphamide"

    NDCBrand NameGeneric Name
    0054-0382CyclophosphamideCyclophosphamide
    0054-0383CyclophosphamideCyclophosphamide
    0781-3233Cyclophosphamidecyclophosphamide
    0781-3244Cyclophosphamidecyclophosphamide
    0781-3255Cyclophosphamidecyclophosphamide
    10019-935CYCLOPHOSPHAMIDEcyclophosphamide
    10019-936CYCLOPHOSPHAMIDEcyclophosphamide
    10019-937CYCLOPHOSPHAMIDEcyclophosphamide
    10019-938CYCLOPHOSPHAMIDEcyclophosphamide
    10019-939CYCLOPHOSPHAMIDEcyclophosphamide
    10019-942CYCLOPHOSPHAMIDEcyclophosphamide
    10019-943CYCLOPHOSPHAMIDEcyclophosphamide
    10019-944CYCLOPHOSPHAMIDEcyclophosphamide
    68001-370CyclophosphamideCyclophosphamide
    68001-372CyclophosphamideCyclophosphamide
    68001-371CyclophosphamideCyclophosphamide
    69097-516CyclophosphamideCyclophosphamide
    69097-517CyclophosphamideCyclophosphamide
    70121-1239CyclophosphamideCyclophosphamide
    70121-1240CyclophosphamideCyclophosphamide
    70121-1238CyclophosphamideCyclophosphamide
    10019-955CyclophosphamideCyclophosphamide
    10019-988CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    10019-957CyclophosphamideCyclophosphamide
    10019-989CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    10019-990CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    10019-945CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    10019-956CyclophosphamideCyclophosphamide
    16714-859CyclophosphamideCyclophosphamide
    16714-857CyclophosphamideCyclophosphamide
    16714-858CyclophosphamideCyclophosphamide
    43975-308CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    43975-307CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    54879-022CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    54879-021CYCLOPHOSPHAMIDECYCLOPHOSPHAMIDE
    72603-411CyclophosphamideCyclophosphamide
    72603-104CyclophosphamideCyclophosphamide
    72603-326CyclophosphamideCyclophosphamide
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.